Iodine Supplement Strategies Between Routine Iodine Supplementation and Selective Iodine Supplementation
NCT03078140 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 208
Last updated 2026-03-18
Summary
Pregnant women who attend at our antenatal clinic will random to 2 groups. First will receive routine iodine supplementation. The other will receive iodinated pill or only iron supplementation base on their urine iodine status.
Conditions
- Pregnancy Related
- Iodine Deficiency
Interventions
- DIETARY_SUPPLEMENT
-
Triferdine
Triferdine 1 tablet daily Start from 14 weeks of gestation until delivery
- DIETARY_SUPPLEMENT
-
Triferdine/Ferli-6
For the participants assigned to this group, urine iodine level will be checked first. For participants with normal urine iodine level, Ferli-6 1 tab daily will be given. For those with low urine iodine level, Triferdine 1 tab daily will be given. Medication will be started from 14 weeks of gestation until delivery.
Sponsors & Collaborators
-
Chiang Mai University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-05-01
- Primary Completion
- 2018-04-30
- Completion
- 2018-05-31
Countries
- Thailand
Study Locations
More Related Trials
-
A Randomised Controlled Trial of Iodide Supplementation in Preterm Infants Follow-up at 2 Years
NCT00638092 ·Status: COMPLETED ·Phase: PHASE4
-
Iodine Status in Pregnant Women and Their Newborns: is Congenital Hypothyroidism Related to Iodine Deficiency in Pregnancy?
NCT00505479 ·Status: UNKNOWN
-
Iodine Supplementation in Graves' Hyperthyroidism
NCT06540469 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Serum Thyroid Function After Iodinated Contrast Administration
NCT05786846 ·Status: UNKNOWN
-
A Trial for the Evaluation of the Treatment and Outcome of Hyperthyroidism With Iodized Salt and Non Iodized Salt
NCT03444246 ·Status: UNKNOWN ·Phase: NA
-
Selenium Supplementation in Pregnancy
NCT01465867 ·Status: COMPLETED ·Phase: NA
-
Relation Between Maternal Iodine Status and Prenatal Foetal Thyroid Dimension
NCT00162539 ·Status: COMPLETED ·Phase: NA
-
Iodine Impact on Thyroid Function and Psychomotor Development, Observational Study in the Portuguese Minho Region
NCT04288531 ·Status: ACTIVE_NOT_RECRUITING
-
Swedish Iodine in Pregnancy and Development in Children (SWIDDICH) Study
NCT02378246 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Iodine Supplementation in Obesity
NCT01985204 ·Status: COMPLETED ·Phase: NA
-
Serum Thyroglobulin as a Marker of Iodine Status During Pregnancy
NCT02927119 ·Status: COMPLETED
-
Phase 4 Study in Secondary Hypothyroidism: Body Weight Adapted Thyroxin Treatment and Triiodothyronine Supplementation
NCT00360074 ·Status: COMPLETED ·Phase: PHASE4
-
Iodine Status in Pregnant Women in Israel
NCT03120221 ·Status: UNKNOWN
-
An Iodine Balance Study to Investigate the Recommended Iodine Intake in an Elderly Population
NCT06218043 ·Status: RECRUITING ·Phase: NA
-
Iodine Nutrition Status and Clinical Characteristics of Thyroid Cancer
NCT06623500 ·Status: RECRUITING
-
Iodine Status and Characteristics of Papillary Thyroid Cancer
NCT06626581 ·Status: NOT_YET_RECRUITING
-
The Prospective Study of Standard Treatment of Graves Disease Iodine 131 and Prevention of Adverse Reactions
NCT01204359 ·Status: UNKNOWN ·Phase: PHASE3
-
Study on the Relationship Between Iodine Nutrition and Thyroid Diseases in the Elderly
NCT05716191 ·Status: RECRUITING
-
Thyroid Therapy for Mild Thyroid Deficiency in Pregnancy
NCT00388297 ·Status: COMPLETED ·Phase: PHASE3
-
Enhancing Radioiodine Incorporation Into Radio Iodine Refractory Thyroid Cancers With MAPK Inhibition
NCT04619316 ·Status: UNKNOWN ·Phase: PHASE2
-
The Establish of Specific Reference Ranges for Thyroid Tests in Pregnant Women
NCT02966405 ·Status: UNKNOWN
-
Desiccated Thyroid Extract and Levothyroxine for Hypothyroidism Treatment
NCT01739972 ·Status: UNKNOWN ·Phase: NA
-
Desiccated Thyroid Extract Versus Synthetic T3/T4 Combination (ThyrolarTM) Versus L-T4 Alone in the Therapy of Primary Hypothyroidism With Special Attention to the Gene Polymorphism
NCT02317926 ·Status: UNKNOWN ·Phase: NA
-
Iodine I-131 With or Without Selumetinib in Treating Patients With Recurrent or Metastatic Thyroid Cancer
NCT02393690 ·Status: COMPLETED ·Phase: PHASE2
-
Testing a Web-based Intervention for Radioactive Iodine Symptom Management to Improve Health-related Quality of Life Among Differentiated Thyroid Cancer Patients
NCT06853925 ·Status: RECRUITING ·Phase: NA